Our data are in line with the role of CD137 as a relevant immunosuppressive molecule Treg-associated in the tumor microenvironment, different from what observed in periphery [49], and in agreement with an infiltrating CCR8+ICOS+ CD8+ Treg signature of disease progression found in NSCLC [50]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.